MARATTO

article · Journal of Drug Delivery Science and Technology

Surface modified/controlled release amikacin-loaded lipidic-based hybrid nanovesicles: Quality by Design (QbD) endorsed fabrication and pharmacokinetic assessment of a BCS Class III drug

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Advancements in Transdermal Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Lipid Membrane Structure and Behavior

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.jddst.2026.108677

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.